Raza in the News Carolyn Bonner 10/16/23 Carolyn Bonner 10/16/23 Dr. Raza Bokhari, Former Executive Chairman and CEO of FSD Pharma, Provides Litigation UpdateFiles a Motion For Leave Of Court and raises concern over investment strategy of FSD Pharma Read More Carolyn Bonner 10/13/23 Carolyn Bonner 10/13/23 Medicus Pharma Ltd. Announces Commencement of Trading on TSX Venture Exchange and Appointment of Seasoned Pharma Executive Barry Fishman to the Board of Directors Read More Carolyn Bonner 10/4/23 Carolyn Bonner 10/4/23 Medicus Pharma Ltd. Announces Closing of Business Combination Read More Padilla Development 6/21/23 Padilla Development 6/21/23 Dr. Raza Bokhari, Former Executive Chairman and CEO of FSD Pharma, Files Two Additional Claims Against the Company Seeking Relief and Monetary Damages Exceeding $30.2 Million Read More Padilla Development 4/18/23 Padilla Development 4/18/23 SkinJect, an innovator in skin cancer treatment, is backed by US healthcare private equity and institutional investors, including RBx Capital, LP and Velocity Fund Partners Read More fsd Padilla Development 6/22/20 fsd Padilla Development 6/22/20 FSD Pharma Inc. Rings the Opening Bell Read More fsd Padilla Development 6/8/20 fsd Padilla Development 6/8/20 FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND Read More fsd Padilla Development 3/6/20 fsd Padilla Development 3/6/20 Full interview: FSD Pharma rings the bell to open trading day on the Canadian Securities Exchange Read More fsd Padilla Development 6/3/19 fsd Padilla Development 6/3/19 FSD Pharma removes the 'interim' from CEO Raza Bokhari's title Read More
Carolyn Bonner 10/16/23 Carolyn Bonner 10/16/23 Dr. Raza Bokhari, Former Executive Chairman and CEO of FSD Pharma, Provides Litigation UpdateFiles a Motion For Leave Of Court and raises concern over investment strategy of FSD Pharma Read More
Carolyn Bonner 10/13/23 Carolyn Bonner 10/13/23 Medicus Pharma Ltd. Announces Commencement of Trading on TSX Venture Exchange and Appointment of Seasoned Pharma Executive Barry Fishman to the Board of Directors Read More
Carolyn Bonner 10/4/23 Carolyn Bonner 10/4/23 Medicus Pharma Ltd. Announces Closing of Business Combination Read More
Padilla Development 6/21/23 Padilla Development 6/21/23 Dr. Raza Bokhari, Former Executive Chairman and CEO of FSD Pharma, Files Two Additional Claims Against the Company Seeking Relief and Monetary Damages Exceeding $30.2 Million Read More
Padilla Development 4/18/23 Padilla Development 4/18/23 SkinJect, an innovator in skin cancer treatment, is backed by US healthcare private equity and institutional investors, including RBx Capital, LP and Velocity Fund Partners Read More
fsd Padilla Development 6/22/20 fsd Padilla Development 6/22/20 FSD Pharma Inc. Rings the Opening Bell Read More
fsd Padilla Development 6/8/20 fsd Padilla Development 6/8/20 FSD Pharma aims to initiate a Phase 2 coronavirus treatment trial by end 2020 as it files IND Read More
fsd Padilla Development 3/6/20 fsd Padilla Development 3/6/20 Full interview: FSD Pharma rings the bell to open trading day on the Canadian Securities Exchange Read More
fsd Padilla Development 6/3/19 fsd Padilla Development 6/3/19 FSD Pharma removes the 'interim' from CEO Raza Bokhari's title Read More